<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Tylenol &#8211; Canyon Crest Guide Local News</title>
	<atom:link href="https://canyoncrestguide.com/tag/tylenol/feed/" rel="self" type="application/rss+xml" />
	<link>https://canyoncrestguide.com</link>
	<description>Canyon Crest News</description>
	<lastBuildDate>Mon, 03 Nov 2025 19:02:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://canyoncrestguide.com/wp-content/uploads/2023/08/Canyon-Crest-Guide-Local-News-100x100-1-65x65.jpeg</url>
	<title>Tylenol &#8211; Canyon Crest Guide Local News</title>
	<link>https://canyoncrestguide.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal</title>
		<link>https://canyoncrestguide.com/kimberly-clark-buying-tylenol-maker-kenvue-in-48-7-billion-deal/</link>
		
		<dc:creator><![CDATA[Tony Ramos]]></dc:creator>
		<pubDate>Mon, 03 Nov 2025 19:02:19 +0000</pubDate>
				<category><![CDATA[Daily News]]></category>
		<category><![CDATA[127127353]]></category>
		<category><![CDATA[article]]></category>
		<category><![CDATA[billion]]></category>
		<category><![CDATA[business]]></category>
		<category><![CDATA[buying]]></category>
		<category><![CDATA[deal]]></category>
		<category><![CDATA[General news]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Kenvue]]></category>
		<category><![CDATA[KimberlyClark]]></category>
		<category><![CDATA[Maker]]></category>
		<category><![CDATA[Pain management]]></category>
		<category><![CDATA[Tylenol]]></category>
		<category><![CDATA[U.S. news]]></category>
		<guid isPermaLink="false">https://canyoncrestguide.com/kimberly-clark-buying-tylenol-maker-kenvue-in-48-7-billion-deal/</guid>

					<description><![CDATA[[ad_1] Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark, whose brands include Huggies, Kleenex and Cottonelle, will own about 54% of the combined company. Kenvue shareholders will own about 46%. Kenvue has spent a relatively brief period [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal</title>
		<link>https://canyoncrestguide.com/kimberly-clark-to-acquire-tylenol-maker-kenvue-in-48-7-billion-deal/</link>
		
		<dc:creator><![CDATA[Tony Ramos]]></dc:creator>
		<pubDate>Mon, 03 Nov 2025 12:56:10 +0000</pubDate>
				<category><![CDATA[Daily News]]></category>
		<category><![CDATA[acquire]]></category>
		<category><![CDATA[billion]]></category>
		<category><![CDATA[deal]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Kenvue]]></category>
		<category><![CDATA[KimberlyClark]]></category>
		<category><![CDATA[Maker]]></category>
		<category><![CDATA[Tylenol]]></category>
		<guid isPermaLink="false">https://canyoncrestguide.com/kimberly-clark-to-acquire-tylenol-maker-kenvue-in-48-7-billion-deal/</guid>

					<description><![CDATA[[ad_1] Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining the Huggies manufacturer with the owner of Aveeno and Band-Aid. Kenvue shareholders will receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue share held at closing. That amounts to [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Video Medical groups push back on Trump administration&#8217;s Tylenol and autism claims</title>
		<link>https://canyoncrestguide.com/video-medical-groups-push-back-on-trump-administrations-tylenol-and-autism-claims/</link>
		
		<dc:creator><![CDATA[Tony Ramos]]></dc:creator>
		<pubDate>Tue, 23 Sep 2025 18:16:09 +0000</pubDate>
				<category><![CDATA[Daily News]]></category>
		<category><![CDATA[administrations]]></category>
		<category><![CDATA[Autism]]></category>
		<category><![CDATA[claims]]></category>
		<category><![CDATA[groups]]></category>
		<category><![CDATA[MediCal]]></category>
		<category><![CDATA[push]]></category>
		<category><![CDATA[trump]]></category>
		<category><![CDATA[Tylenol]]></category>
		<category><![CDATA[video]]></category>
		<guid isPermaLink="false">https://canyoncrestguide.com/video-medical-groups-push-back-on-trump-administrations-tylenol-and-autism-claims/</guid>

					<description><![CDATA[[ad_1] Medical groups push back on Trump administration&#8217;s Tylenol and autism claims Major medical organizations are pushing back against the Trump admin’s claim that the use of Tylenol during pregnancy may be linked to an increased risk of autism. September 23, 2025 [ad_2] Source link]]></description>
		
		
		
			</item>
		<item>
		<title>Trump admin links Tylenol use in pregnancy to increased risk of autism despite mixed studies</title>
		<link>https://canyoncrestguide.com/trump-admin-links-tylenol-use-in-pregnancy-to-increased-risk-of-autism-despite-mixed-studies/</link>
		
		<dc:creator><![CDATA[Tony Ramos]]></dc:creator>
		<pubDate>Mon, 22 Sep 2025 23:56:19 +0000</pubDate>
				<category><![CDATA[Daily News]]></category>
		<category><![CDATA[125802080]]></category>
		<category><![CDATA[admin]]></category>
		<category><![CDATA[article]]></category>
		<category><![CDATA[Autism]]></category>
		<category><![CDATA[Increased]]></category>
		<category><![CDATA[links]]></category>
		<category><![CDATA[mixed]]></category>
		<category><![CDATA[pregnancy]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[Studies]]></category>
		<category><![CDATA[trump]]></category>
		<category><![CDATA[Tylenol]]></category>
		<guid isPermaLink="false">https://canyoncrestguide.com/trump-admin-links-tylenol-use-in-pregnancy-to-increased-risk-of-autism-despite-mixed-studies/</guid>

					<description><![CDATA[[ad_1] The Trump administration stated on Monday that the use of Tylenol during pregnancy may be linked to an increased risk of autism. In a press conference at the White House, President Donald Trump said the Food and Drug Administration will begin notifying physicians immediately that it is &#8220;strongly recommending that women limit Tylenol use [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Dan Loeb’s Third Point builds stake in maker of Tylenol and Neutrogena</title>
		<link>https://canyoncrestguide.com/dan-loebs-third-point-builds-stake-in-maker-of-tylenol-and-neutrogena/</link>
		
		<dc:creator><![CDATA[Tony Ramos]]></dc:creator>
		<pubDate>Fri, 25 Apr 2025 19:18:00 +0000</pubDate>
				<category><![CDATA[Daily News]]></category>
		<category><![CDATA[builds]]></category>
		<category><![CDATA[Dan]]></category>
		<category><![CDATA[Loebs]]></category>
		<category><![CDATA[Maker]]></category>
		<category><![CDATA[Neutrogena]]></category>
		<category><![CDATA[point]]></category>
		<category><![CDATA[stake]]></category>
		<category><![CDATA[Tylenol]]></category>
		<guid isPermaLink="false">https://canyoncrestguide.com/dan-loebs-third-point-builds-stake-in-maker-of-tylenol-and-neutrogena/</guid>

					<description><![CDATA[[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Dan Loeb’s Third Point Capital has built a stake in Tylenol and Neutrogena maker Kenvue, becoming the third activist hedge fund to target the $43bn consumer health group in recent months, said people familiar [&#8230;]]]></description>
		
		
		
			</item>
	</channel>
</rss>
